⏳ TONIGHT: Our Wefunder Campaign Closes at 11:59 PM ET ⏳
Published on Apr 7
As we approach the final hours, we want to speak from the heart.
This journey has never just been about raising capital—it’s been about building a movement. A movement to rethink how we treat inflammation. A movement to bring fast, affordable, non-addictive therapeutics to the world. A movement that puts people before profit—without sacrificing either.
Together, we’ve taken big steps:
✨ Advanced 5 lead assets to Phase 2 Clinical Trials
✨ Built a patent-protected portfolio with global reach
✨ Secured formulation and manufacturing with KVK Tech
✨ Completed Market Analysis & Valuation for 2 Asset
✨ Engaged with Destum Partners to seek Strategic Partners for 2 lead assets
But this is just the beginning.
We see a future where SJP-001 redefines how the world manages alcohol-related inflammation. Where SJP-002C and SJP-005 revolutionize care for the common cold and opioid withdrawal. Where Sen-Jam becomes a household name—not because we marketed well, but because we delivered real relief to millions.
And those who helped us get there? They'll share in the success.
💥 Tonight is your last chance to invest in that future and secure your share in the upside through our Fractional Royalty Rights—before this chapter closes forever.
To our incredible 1,100+ investors, our cheerleaders, our believers—thank you.
You didn’t just fund a company. You fueled a vision.
Let’s finish this together—stronger than ever.
With gratitude,
The Sen-Jam Team
